CMA
CLB icon

Cedar Mountain Advisors’s Core Laboratories CLB Stock Holding History

Cedar Mountain Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$722 Sell
62
-68
-52% -$971 ﹤0.01% 992
2026
Q1 		$2.18K Hold
130
– – ﹤0.01% 811
2025
Q4 		$2.08K Buy
130
+3
+2% +$45 ﹤0.01% 395
2025
Q3 		$1.57K Buy
+127
New +$1.49K ﹤0.01% 453

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Cedar Mountain Advisors's CLB Position: Q2 2026 in Review

Cedar Mountain Advisors reduced its Core Laboratories (CLB) stake by 52% in Q2 2026, selling an estimated $971 and leaving 62 shares worth $722. The position accounts for ﹤0.01% of the portfolio, ranked #992.

Cedar Mountain Advisors first reported a position in CLB in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.18K in Q1 2026. 187 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Cedar Mountain Advisors held 62 shares of Core Laboratories worth $722 as of Q2 2026.
  • Cedar Mountain Advisors sold 68 Core Laboratories shares in Q2 2026, an estimated $971.
  • Core Laboratories made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #992 holding.
  • Cedar Mountain Advisors first reported a position in Core Laboratories in Q3 2025 and has held it in 4 quarters since.
  • Cedar Mountain Advisors's Core Laboratories position peaked at $2.18K in Q1 2026.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.